Pediatric Inflammatory Bowel Disease: A Multicenter Study of Changing Trends in Argentina Over the Past 30 Years

Maria Soledad Arcucci1, Monica Beatriz Contreras2, Julieta Gallo1

  • 1Pediatric Gastroenterology, Hepatology and Liver Intestinal Transplantation Unit, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.

Insights

Pediatric inflammatory bowel disease (IBD) in Argentina shows a rising trend in Crohn's disease (CD) and a decrease in ulcerative colitis (UC) over 30 years. Surgical treatments declined with the introduction of biological therapies.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Epidemiology

Background:

  • Pediatric inflammatory bowel disease (IBD) encompasses chronic conditions like ulcerative colitis (UC) and Crohn's disease (CD).
  • Understanding long-term trends in pediatric IBD is crucial for public health and clinical management.

Purpose of the Study:

  • To analyze the 30-year characteristics of pediatric IBD in Argentina.
  • To identify changes in IBD demographics and treatment between 1987-2007 and 2008-2017.

Main Methods:

  • Retrospective, multicenter study of 756 children (0-18 years) diagnosed between 1987-2017.
  • Data collected included clinical, endoscopic, histologic, and imaging findings, along with therapeutic strategies.
  • Patients were grouped into two cohorts: 1987-2007 and 2008-2017.

Main Results:

  • Ulcerative colitis (UC) affected 54%, Crohn's disease (CD) 33%, and IBD-unclassified (IBD-U) 13% of patients.
  • An increasing incidence of CD and a decreasing incidence of UC/IBD-U were observed in the last decade.
  • A 50% reduction in surgeries coincided with the introduction of biological therapies.

Conclusions:

  • This is the first multicenter cohort study on pediatric IBD in Latin America over three decades.
  • While CD incidence increased, UC remains prevalent in Argentina.
  • Shifting treatment paradigms reflect the impact of advanced therapies.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
434
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
206
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
410
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
352
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
281
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
230